This inventor holds 3 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2011-2023.
Company Filing History:
Years Active: 2011-2023
Title: Tetsuro Ikegami: Innovator in Vaccine Development
Introduction
Tetsuro Ikegami is a prominent inventor based in Galveston, TX (US). He has made significant contributions to the field of vaccine development, particularly in relation to the Rift Valley fever virus. With a total of 3 patents to his name, Ikegami's work is vital in advancing medical science and public health.
Latest Patents
Ikegami's latest patents include an improved Rift Valley fever vaccine designed for human use. This innovative vaccine aims to enhance the safety and efficacy of immunization against this viral disease. Another notable patent involves a recombinant Rift Valley fever virus that encodes a dominant-negative inhibitor of dsRNA-dependent protein kinase in the NSS region. This invention focuses on methods and compositions that utilize a heterologous nucleic acid to improve the virus's therapeutic potential.
Career Highlights
Ikegami is affiliated with the University of Texas System, where he conducts his research and development work. His career is marked by a commitment to understanding and combating viral diseases, particularly those that pose significant health risks to humans.
Collaborations
Throughout his career, Ikegami has collaborated with esteemed colleagues such as Shinji Makino and Clarence J Peters. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Tetsuro Ikegami's contributions to vaccine development, particularly in relation to the Rift Valley fever virus, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has the potential to improve public health outcomes.